Jarushka Naidoo

Research interests

Publications

• Immune-related adverse events and the balancing act of immunotherapy

  Nature Communications · 2022 · https://doi.org/10.1038/s41467-022-27960-2

• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

  Journal for ImmunoTherapy of Cancer · 2021 · https://doi.org/10.1136/jitc-2021-002435

• Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial

  Journal of Thoracic Oncology · 2021 · https://doi.org/10.1016/j.jtho.2020.12.015

• Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

  Journal for ImmunoTherapy of Cancer · 2021 · https://doi.org/10.1136/jitc-2020-001731

• Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

  Nature · 2021 · https://doi.org/10.1038/s41586-021-03752-4

• Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

  Journal for ImmunoTherapy of Cancer · 2021 · 10.1136/jitc-2021-002890

• NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

  Journal of the National Comprehensive Cancer Network · 2020 · https://doi.org/10.6004/jnccn.2020.0012

• Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

  Nature Cancer · 2020 · 10.1038/s43018-019-0008-8

• Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer

  JAMA Oncology · 2020 · https://doi.org/10.1001/jamaoncol.2020.5012

• Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

  Journal of Clinical Oncology · 2019 · 10.1200/jco.19.01674

• Genome-wide cell-free DNA fragmentation in patients with cancer

  Nature · 2019 · https://doi.org/10.1038/s41586-019-1272-6

• Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2019 · https://doi.org/10.6004/jnccn.2019.0013

• The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis

  Journal of Clinical Investigation · 2019 · https://doi.org/10.1172/jci128654

• Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.00320

• Cardiovascular toxicities associated with immune checkpoint inhibitors

  Cardiovascular Research · 2019 · https://doi.org/10.1093/cvr/cvz026

• Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

  Annals of the Rheumatic Diseases · 2019 · 10.1136/annrheumdis-2019-216109

• Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen

  Seminars in Arthritis and Rheumatism · 2018 · https://doi.org/10.1016/j.semarthrit.2018.02.011

• Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.11.016

• Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer

  CHEST Journal · 2018 · https://doi.org/10.1016/j.chest.2018.08.1048

• Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.08.2035

• Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

  Cancer Research · 2018 · 10.1158/0008-5472.can-18-1127

• Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1716078

• Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

  International Journal of Radiation Oncology*Biology*Physics · 2017 · https://doi.org/10.1016/j.ijrobp.2017.11.041

• Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

  Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-16-0828

• Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1

  Cancer Immunology Research · 2016 · 10.1158/2326-6066.cir-15-0123

• Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2016.68.2005

• Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets

  Clinical Cancer Research · 2016 · https://doi.org/10.1158/1078-0432.ccr-15-2946

• Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209595

• Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

  Annals of Oncology · 2015 · 10.1093/annonc/mdv383

• Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib

  Cancer · 2015 · 10.1002/cncr.29493

Current projects

No projects listed.